Intrinsiqq
Alzinova AB logo

Alzinova AB Financials

ALZ.XSTO

Compare

All currency values in kr millions unless otherwise noted

Scroll

Income Statement
TTM
DEC 2025
DEC 2024
DEC 2023
DEC 2022
DEC 2021
Revenues
Revenuekr 0kr 0kr 0kr 0kr 0kr 0
Cost of Revenue-kr 15-kr 27-kr 17-kr 20-kr 17-kr 17
Gross Profitkr 15kr 27kr 17kr 20kr 17kr 17
Total Operating Expenseskr 38kr 52kr 37kr 36kr 30kr 25
Operating Income-kr 23-kr 26-kr 20-kr 17-kr 13-kr 8
Non-Operating
Net Interest Expense-kr 2-kr 1-kr 0-kr 0-kr 0-kr 0
Net Income
Net Income-kr 24-kr 26-kr 21-kr 16-kr 13-kr 8
Per Share Data
Revenue Per Sharekr 0.00kr 0.00kr 0.00kr 0.01kr 0.00kr 0.00
EPS (Basic)-kr 0.22-kr 0.25-kr 0.31-kr 0.33-kr 0.44-kr 0.39
EPS (Diluted)-kr 0.22-kr 0.25-kr 0.31-kr 0.33-kr 0.44-kr 0.39
Shares Outstanding162.2M104.3M66.3M49.6M29.9M19.4M

Alzinova AB (ALZ.XSTO) financials: revenue, profit and margins

Alzinova AB (ALZ.XSTO) generated about SEK 0.00 in revenue and -SEK 24 million in net income over the trailing twelve months. Figures are from company filings; this is analysis, not investment advice.

Frequently asked

What is Alzinova AB's (ALZ.XSTO) revenue?+

Alzinova AB generated about SEK 0.00 in revenue over the trailing twelve months. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.

Is Alzinova AB profitable?+

Alzinova AB reported about -SEK 24 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

How the market compares: How many US companies are profitable

Peers

Biotechnology · Pick stocks to compare with ALZ.XSTO

CompareIntrinsic value
NEWBRY.XSTONewbury Pharmaceuticals AB
€0.11+0.91%40
NXTCL.XSTONextCell Pharma AB
€0.01+18.52%50
KDEV.XSTOKDventures AB
kr 0.14+6.06%25
BIOSGN.XSTOBiosergen AB
No recent price20
HEART.XSTOScandinavian Real Heart AB
€1.28-0.39%10
2CUREX.XSTO2cureX AB
No recent price10
APOTEA.XSTOApotea AB
€9.00-0.94%71
XVIVO.XSTOXVIVO Perfusion AB
kr 197.15+1.00%44

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing ALZ.XSTO

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.